A

Agile Therapeutics Inc
OTC:AGRX

Watchlist Manager
Agile Therapeutics Inc
OTC:AGRX
Watchlist
Price: 0.6022 USD Market Closed
Market Cap: 10.4m USD

Wall Street
Price Targets

AGRX Price Targets Summary
Agile Therapeutics Inc

There are no price targets for AGRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Agile Therapeutics Inc Competitors:
Price Targets
4523
Eisai Co Ltd
6% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
52% Upside
1093
CSPC Pharmaceutical Group Ltd
16% Upside
DMP
Dermapharm Holding SE
11% Upside
ANCR
Animalcare Group PLC
39% Upside
002653
Haisco Pharmaceutical Group Co Ltd
80% Upside
BMY
Bristol-Myers Squibb Co
1% Upside
CPH
Cipher Pharmaceuticals Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Agile Therapeutics Inc

The compound annual growth rate of Agile Therapeutics Inc's revenue for the next 1 year is 81%.

N/A
Past Growth
81%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Agile Therapeutics Inc

Operating Income forecast
is not available for
Agile Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Agile Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGRX's stock price target?
Not Available

AGRX doesn't have any price targets made by Wall Street professionals.

What is Agile Therapeutics Inc's Revenue forecast?
Projected CAGR
81%

The compound annual growth rate of Agile Therapeutics Inc's revenue for the next 1 year is 81%.

Back to Top